Zhai et al. also found that GBM patients with high levels of BACE1 always have worse prognosis and shorter survival, and the inhibition of BACE1 promotes a switch from M2 to M1 TAMs, which suppresses GBM growth. Here, BACE1 is linked to glioblastoma.